Antisense Knockdown of PKC-α Using LNA-Oligos
- 1 October 2003
- journal article
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 22 (5-8) , 1607-1609
Abstract
Full-length and 4 nucleotides truncated Locked Nucleic Acid (LNA) modifications of ISIS 3521 were compared for antisense properties in a cellular assay. ISIS 3521 is a 20-mer phosphorothioate designed to hybridise to human protein kinase C-α (PKC-α) mRNA and is currently submitted to clinical trials against cancer. We report that LNA can potentate this antisense oligo and retain the antisense potential with shorter oligos.Keywords
This publication has 4 references indexed in Scilit:
- Design of antisense oligonucleotides stabilized by locked nucleic acidsNucleic Acids Research, 2002
- Potent and nontoxic antisense oligonucleotides containing locked nucleic acidsProceedings of the National Academy of Sciences, 2000
- LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognitionTetrahedron, 1998
- Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.Journal of Biological Chemistry, 1994